GB1576016A - Pharmaceutical compositions containing polyvinylbenzenesulphonic acids - Google Patents

Pharmaceutical compositions containing polyvinylbenzenesulphonic acids Download PDF

Info

Publication number
GB1576016A
GB1576016A GB3419/77A GB341977A GB1576016A GB 1576016 A GB1576016 A GB 1576016A GB 3419/77 A GB3419/77 A GB 3419/77A GB 341977 A GB341977 A GB 341977A GB 1576016 A GB1576016 A GB 1576016A
Authority
GB
United Kingdom
Prior art keywords
therapeutic composition
molecular weight
polymeric mixture
units
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3419/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohm and Haas Co
Original Assignee
Rohm and Haas Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm and Haas Co filed Critical Rohm and Haas Co
Publication of GB1576016A publication Critical patent/GB1576016A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F12/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an aromatic carbocyclic ring
    • C08F12/02—Monomers containing only one unsaturated aliphatic radical
    • C08F12/04—Monomers containing only one unsaturated aliphatic radical containing one ring
    • C08F12/14—Monomers containing only one unsaturated aliphatic radical containing one ring substituted by hetero atoms or groups containing heteroatoms
    • C08F12/30—Sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/10—Copolymer characterised by the proportions of the comonomers expressed as molar percentages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages
GB3419/77A 1976-02-04 1977-01-27 Pharmaceutical compositions containing polyvinylbenzenesulphonic acids Expired GB1576016A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65520076A 1976-02-04 1976-02-04
US75269376A 1976-12-20 1976-12-20

Publications (1)

Publication Number Publication Date
GB1576016A true GB1576016A (en) 1980-10-01

Family

ID=27096927

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3419/77A Expired GB1576016A (en) 1976-02-04 1977-01-27 Pharmaceutical compositions containing polyvinylbenzenesulphonic acids

Country Status (10)

Country Link
JP (1) JPS5296748A (sv)
AU (1) AU514389B2 (sv)
CA (1) CA1114997A (sv)
DE (1) DE2704329A1 (sv)
DK (1) DK44777A (sv)
FR (1) FR2340330A1 (sv)
GB (1) GB1576016A (sv)
IE (1) IE44690B1 (sv)
NL (1) NL7701168A (sv)
SE (2) SE430070B (sv)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105982A1 (en) * 1980-07-25 1984-04-25 Johnson & Johnson Products Inc. Sulfonated vinylaromatic homopolymers and copolymers as dental plaque barriers
WO2004009100A1 (en) * 2002-07-22 2004-01-29 Genzyme Corporation Poly (potassium and sodium styrene sulfonate), its manufacture and its uses
EP1800686A2 (en) * 1999-05-13 2007-06-27 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
US7678369B2 (en) 1999-05-13 2010-03-16 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395392A (en) * 1980-06-24 1983-07-26 Adria Laboratories Inc. Method for treating kidney stones
US4432967A (en) * 1982-06-25 1984-02-21 National Starch And Chemical Corp. Contraceptive composition
EP0579153B1 (en) * 1992-07-13 1998-04-08 Tosoh Corporation Process for producing tertiary alcohols
US6270755B1 (en) 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
WO2003099881A1 (en) * 2001-01-11 2003-12-04 Sony Corporation Ion-conductive polymer, solid polyelectrolyte, and cell employing the same
AU2003903547A0 (en) * 2003-07-10 2003-07-24 Neoferma Australia Pty Ltd Structures and methods of waterproofing same
JP6271378B2 (ja) * 2014-09-05 2018-01-31 信越化学工業株式会社 導電性ポリマー用高分子化合物及びその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3310481A (en) * 1962-09-10 1967-03-21 Dow Chemical Co Removal of residual monomeric sulfonates from polymerizates thereof
JPS4936644A (sv) * 1972-08-15 1974-04-05

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0105982A1 (en) * 1980-07-25 1984-04-25 Johnson & Johnson Products Inc. Sulfonated vinylaromatic homopolymers and copolymers as dental plaque barriers
EP1800686A2 (en) * 1999-05-13 2007-06-27 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
EP1800687A2 (en) * 1999-05-13 2007-06-27 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
EP1800687A3 (en) * 1999-05-13 2009-12-30 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
EP1800686A3 (en) * 1999-05-13 2009-12-30 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
US7678369B2 (en) 1999-05-13 2010-03-16 Genzyme Corporation Anionic polymers as toxin binders and antibacterial agents
WO2004009100A1 (en) * 2002-07-22 2004-01-29 Genzyme Corporation Poly (potassium and sodium styrene sulfonate), its manufacture and its uses
CN100411625C (zh) * 2002-07-22 2008-08-20 基酶有限公司 聚(钾和钠的苯乙烯苯磺酸盐),其制备及其用途

Also Published As

Publication number Publication date
SE8106138L (sv) 1981-10-16
IE44690L (en) 1977-08-04
CA1114997A (en) 1981-12-22
DE2704329A1 (de) 1977-08-18
AU514389B2 (en) 1981-02-05
FR2340330B1 (sv) 1981-05-29
SE7700670L (sv) 1977-08-05
NL7701168A (nl) 1977-08-08
SE426835B (sv) 1983-02-14
IE44690B1 (en) 1982-02-24
SE430070B (sv) 1983-10-17
FR2340330A1 (fr) 1977-09-02
JPS5296748A (en) 1977-08-13
DK44777A (da) 1977-08-05
AU2193477A (en) 1978-08-10

Similar Documents

Publication Publication Date Title
EP1014999B1 (en) Cationic polymers as toxin-binding agents
CA1117013A (en) Method for treating kidney stones
CA2557999C (en) Methods and compositions for treatment of ion imbalances
GB1576016A (en) Pharmaceutical compositions containing polyvinylbenzenesulphonic acids
JP4649039B2 (ja) 非置換ポリジアリルアミンを用いる高コレステロール血症の治療方法
CN1980645A (zh) 治疗离子平衡紊乱的方法和组合物
CN101321519A (zh) 制备含有交联壳的核-壳型复合物的方法及其得到的核-壳型复合物
EP0162388A1 (en) Novel bile sequestrant resin and uses
EP0375350B1 (en) Cross-linked vinylpyridinium polymers
CA2040996A1 (en) Composition and method for controlling cholesterol
JPS6136494B2 (sv)
US3951949A (en) Sulfates of hydroxyethyl starch
JPH06192129A (ja) 胆汁酸封鎖剤
US4395392A (en) Method for treating kidney stones
US3946035A (en) Anti-inflammatory polymers, pharmaceutical compositions containing the same and process for producing said polymers
EP0249779B1 (en) Methylated chitosans and their use for the preparation of pharmaceutical compositions
US4954339A (en) Novel polystyrene anion exchange polymers
US4003990A (en) Anti-inflammatory polymers, pharmaceutical compositions containing the same and process for producing said polymers
US5230885A (en) Polystyrene anion exchange polymer pharmaceutical composition
BE851113A (fr) Acides polyvinylbenzenesulfoniques, leur procede de preparation et leur application en tant que medicaments
US20230102317A1 (en) Polymer medicament for treating hyperkalemia and preparation method thereof
EP0403271A2 (en) Polymer compounds
CA2082060A1 (en) Therapeutical composition
JPH0448778B2 (sv)
SU482470A1 (ru) Способ получени физиологически водорастворимых полимерных солей

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee